A Decade of Triumph and Advocacy
In an inspiring turn of events, a ten-year survivor of Triple Negative Breast Cancer (TNBC), Sharon Rivera Sanchez has taken to the airwaves to share her journey and advocate for the vital role of patients in clinical trials. As she embarks on her fifth clinical trial since achieving remission, her story underscores the importance of inclusive and patient-centered approaches in medical research.
Featured on the “Race in STEM” Podcast
Recently, Sharon was featured on the “Race in STEM” podcast, where she discussed the often-overlooked perspective of clinical trial participants. Her firsthand experiences shine a light on the challenges and triumphs associated with navigating these trials, particularly as an African American woman. The podcast aims to elevate the voices of those who contribute to the scientific community, emphasizing the need for diversity and representation in clinical research.
A Call for Unity and Collaboration
During the podcast, Sharon emphasized the need for a collective effort to combat cancer. “If we must beat this dreadful disease, we all have to come together, from clinical trial design to survivors,” she stated, highlighting the importance of collaboration between researchers, healthcare providers, and patients.
Driving Awareness and Change
By sharing her story, she hopes to inspire others to get involved in clinical trials and advocate for their health. Her journey is not just a testament to personal resilience but also a call to action for more inclusive trials that reflect the diverse populations affected by cancer.
Connecting with the Community
Through hashtags such as #clinicaltrial, #trialsofcolor, #getchecked, #crc, #tnbc, and #africanamerican, the Sharon continues to engage with the community with boots on the ground and online, fostering a supportive network for those who are navigating similar challenges. Her story can be further explored through the link provided in her social media post.
Sharon’s survivor’s dedication to advocacy and her involvement in clinical trials are not just about personal survival; they are about paving the way for future generations to have access to better, more inclusive healthcare solutions.
Link to the full podcast https://lnkd.in/exm4zhTJ
